The purpose and mission of Translational Analysis in Molecular Medicine (TAMM) is to help scientists at Karolinska Institutet, its associated hospitals, and other academic institutions to perform genetic, epigenetic and genetic-epidemiological research in order to identify and assess genetic factors involved in different disease processes.
The platforms for both genome-wide and targeted analyses include the Agena MassARRAY, the Illumina Iscan, and MiSeq.
TAMM performs zygosity testing as well as sample identification genotyping as a quality control procedure for other laboratories. A major research project has involved the virological typing. In addition, TAMM carries out clinical genetic testing for familial hypercholesterolemia (FH).
The TAMM team consists of clinicians, biologists, IT specialists, bioinformaticians and statisticians.